Imatinib therapy of chronic myeloid leukemia significantly reduces carnitine cell intake, resulting in adverse events
Autor: | Burda, Pavel, Hlavackova, Alzbeta, Polivkova, Vendula, Curik, Nikola, Laznicka, Adam, Krizkova, Jitka, Suttnar, Jiri, Klener, Pavel, Polakova, Katerina Machova |
---|---|
Zdroj: | In Molecular Metabolism October 2024 88 |
Databáze: | ScienceDirect |
Externí odkaz: |